Skip to main content

Find Clinical Trials

Home
Conditions
Type II Diabetes Mellitus

Clinical trial condition

Type II Diabetes Mellitus

Explore clinical trials studying Type II Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

66 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Type II Diabetes Mellitus trial results

Completed

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

NCT00929539

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Birmingham, Alabama, United States

Muscle Shoals, Alabama, United States

Scottsboro, Alabama, United States

Tucson, Arizona, United States

View all 62 locations

View Trial Details

Completed

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

NCT01020123

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Research Site Temuco, Araucania, Chile

Research Site Brentwood, TN, Chile

Research Site Santiago, Chile

Research Site Temuco, Chile

View all 77 locations

View Trial Details

Completed

Yellow Pea Protein and Fibre and Short Term Food Intake

NCT01255085

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +14 more
Locations: University of Toronto - Department of Nutritional Sciences Toronto, Ontario, Canada

View Trial Details

Completed

Yellow Pea Fractions and Short-term Food Intake, Subjective Appetite and Glycemic Response

NCT01242059

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +14 more
Locations: University of Toronto - Department of Nutritional Sciences Toronto, Ontario, Canada

View Trial Details

Completed

Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus

NCT01261494

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations: Site n°12 Banja Luka, Bosnia and Herzegovina

Site n°11 Sarajevo, Bosnia and Herzegovina

Site n°22 Riga, Latvia

Site n°21 Riga, Latvia

View all 28 locations

View Trial Details

Completed

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

NCT00863954

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: pico-tesla Magnetic Therapies Littleton, Colorado, United States

View Trial Details

Completed

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

NCT01196728

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Parexel International GmbH Berlin, State of Berlin, Germany

View Trial Details

Completed

Innovative Strategies For Risk Reduction Following CABG

NCT00462436

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Behavior, +17 more
Locations: St. Michael's Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea

NCT00995787

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Research Site San Diego, California, United States

View Trial Details

Completed

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

NCT00309751

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +7 more
Locations: CCBR Aalborg Aalborg, Denmark

CCBR A/S Ballerup Municipality, Denmark

CCBR Vejle Vejle, Denmark

Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany

View all 35 locations

View Trial Details